(11β,16α)-9-Fluoro-11-Hydroxy-16,17-[(1-Methylethylidene)Bis(Oxy)]-21-(Phosphonooxy)-Pregna-1,4-Diene-3,20-Dione Disodium Sal t

CAS : 1997-15-5

Ref. 3D-FF103709

Informations sur le produit

• Nom: (11β,16α)-9-Fluoro-11-Hydroxy-16,17-[(1-Methylethylidene)Bis(Oxy)]-21-(Phosphonooxy)-Pregna-1,4-Diene-3,20-Dione Disodium Sal t
• Synonymes: 9-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with acetone 21-(dihydrogen phosphate) disodium salt, 9-Fluoro-11β,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with acetone 21-(disodium phosphate), 9α-Fluoro-11β,21-dihydroxy-16α,17α-(isopropylidenedioxy)-1,4-Pregnadiene-3,20-dione 21-(disodium phosphate), 9α-Fluoro-16α-hydroxyprednisolone 16α,17α-acetonide 21-disodium phosphate, Aristosol, Cl 106359, Cl 1965, Cl 53381, Cl 61965, Pregna-1,4-diene-3,20-dione, 9-fluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))-21-(phosphonooxy)-, disodium salt, (11beta,16alpha)-, Pregna-1,4-diene-3,20-dione, 9-fluoro-11-hydroxy-16,17-[(1-methylethylidene)bis(oxy)]-21-(phosphonooxy)-, sodium salt (1:2), (11β,16α)-, Pregna-1,4-diene-3,20-dione, 9-fluoro-11β,16α,17,21-tetrahydroxy-, cyclic 16,17-acetal with acetone, 21-(dihydrogen phosphate), disodium salt, Sodium phosphate triamcinolone acetonide, Triamcinolone acetonide sodium Phosphate [USAN], Triamcinolone acetonide sodium phosphate, disodium 2-[(4aS,4bR,5S,6aS,6bS,9aR,10aS,10bS)-4b-fluoro-5-hydroxy-4a,6a,8,8-tetramethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-6b-yl]-2-oxoethyl phosphate, Pregna-1,4-diene-3,20-dione, 9-fluoro-11-hydroxy-16,17-[(1-methylethylidene)bis(oxy)]-21-(phosphonooxy)-, disodium salt, (11β,16α)-

Description

(11beta,16alpha)-9-Fluoro-11-Hydroxy-16,17-[(1-Methylethylidene)Bis(Oxy)]-21-(Phosphonooxy)-Pregna-1,4-Diene-3,20-Dione Disodium Sal t is a supramolecular drug that inhibits the activity of lipoxygenase. This drug has been shown to be effective in preventing the progression of age related macular degeneration by inhibiting the production of proinflammatory molecules such as leukotrienes and prostaglandins. It also minimizes cataract formation and is used in devices such as intraocular lenses. The molecular structure consists of a steroid nucleus with an annulare ring system that can be injected into tissues and cells. The molecule is bioactive and pharmacologically active when it binds to collagen or amino acids.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 558.44 g/mol
• Formule: C₂₄H₃₀FNa₂O₉P
• Degré de pureté: Min. 95%